Cargando…

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis

BACKGROUND: Median overall survival (OS) of patients with melanoma brain metastases (MBM) is usually 6 months or less. There are rare reports of patients with treated MBM who survived for years. These outlier cases represent valuable opportunities to study the somatic and germline factors that may h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Sarah, Darvishian, Farbod, Tadepalli, Jyothi, Shapiro, Richard, Golfinos, John, Pavlick, Anna, Polsky, David, Kirchhoff, Tomas, Osman, Iman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657192/ https://www.ncbi.nlm.nih.gov/pubmed/26597176 http://dx.doi.org/10.1186/s12885-015-1927-0

Ejemplares similares

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019)

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma
por: Yancovitz, Molly, et al.
Publicado: (2012)

Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011)

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients
por: Yu, Jessie Z, et al.
Publicado: (2008)

Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013)

A genome-wide association study of germline variation and melanoma prognosis
por: Chat, Vylyny, et al.
Publicado: (2023)

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
por: Weiss, Sarah A., et al.
Publicado: (2016)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma
por: Chou, Margaret, et al.
Publicado: (2020)

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
por: Ewens, K. G., et al.
Publicado: (2018)

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014)

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017)

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018)

The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis
por: Moubarak, Rana S., et al.
Publicado: (2022)

Germline MC1R status influences somatic mutation burden in melanoma
por: Robles-Espinoza, Carla Daniela, et al.
Publicado: (2016)

Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
por: Velazquez, Elsa F, et al.
Publicado: (2007)

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer
por: Adamson, A.W., et al.
Publicado: (2023)

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
por: Adamson, A. W., et al.
Publicado: (2023)

Clinical significance of BRAF mutations in metastatic melanoma
por: Chang, David Z, et al.
Publicado: (2004)

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates
por: Ott, Patrick A., et al.
Publicado: (2010)

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
por: Gowen, Michael F., et al.
Publicado: (2018)

Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
por: Yost, Shawn, et al.
Publicado: (2019)

Angiosarcoma of the Breast Masquerading as Hemangioma: Exploring Clinical and Pathological Diagnostic Challenges
por: Frey, Jordan D, et al.
Publicado: (2015)

Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma
por: Colombino, Maria, et al.
Publicado: (2014)

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
por: Casula, Milena, et al.
Publicado: (2019)

Germline competent mesoderm: the substrate for vertebrate germline and somatic stem cells?
por: Savage, Aaron M., et al.
Publicado: (2021)

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants
por: Rayner, Jenna E., et al.
Publicado: (2020)

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
por: Vergani, Elisabetta, et al.
Publicado: (2021)

From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research
por: Muñoz-Barrera, Adrián, et al.
Publicado: (2022)

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
por: Peters, Brandilyn A., et al.
Publicado: (2019)

Joint genotype inference with germline and somatic mutations
por: Bareke, Eric, et al.
Publicado: (2013)

Mediation of organismal aging and somatic proteostasis by the germline
por: Khodakarami, Amirabbas, et al.
Publicado: (2015)

Genetic and Chemical Effects on Somatic and Germline Aging
por: Lee, Myon-Hee, et al.
Publicado: (2020)

Germline and somatic drivers in inherited hematologic malignancies
por: Zoller, Julian, et al.
Publicado: (2023)

Germline genetic host factors as predictive biomarkers in immuno-oncology
por: Chat, Vylyny, et al.
Publicado: (2019)

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
por: Lattanzi, Michael, et al.
Publicado: (2018)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Somatic genetic rescue of a germline ribosome assembly defect
por: Tan, Shengjiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8tajuutebm2u1h8j2o31ulv4d